https://clinicaltrials.gov/ct2/show/NCT04098718?type=Intr&cond=COPD&sfpd_d=14&sel_rss=new14 Acute Exacerbations Treated With BenRAlizumab (The ABRA Study) Conditions : Asthma; COPD Interventions : Drug: Benralizumab; Drug: Prednisolone Sponsor : University of Oxford Not yet recruiting NCT04098718 Mon, 23 Sep 2019 12:00:00 EDT
